KeFu Medical (301087.SZ) announced its performance for the first half of the year, with a net profit attributable to the parent company of 167 million yuan, a year-on-year decrease of 9.51%.

China Fortune Financial News App, Ke Fu Medical (301087.SZ) released its 2025 semi-annual report. During the reporting period, the company achieved operating income of 1.496 billion yuan, a decrease of 4.03% year-on-year. The net profit attributable to the shareholders of the listed company was 167 million yuan, a decrease of 9.51% year-on-year. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 136 million yuan, a decrease of 17.98% year-on-year. The basic earnings per share was 0.82 yuan.